LEADER 01698oam  2200433 a 450 
001 9910697140903321
005 20230902161900.0
035   $a(CKB)5470000002385504
035   $a(OCoLC)612600541
035   $a(EXLCZ)995470000002385504
100   $a20100507d2010      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aMedicare Part D$b[electronic resource] $espending, beneficiary out-of-pocket costs, and efforts to obtain price concessions for certain high-cost drugs : testimony before the Special Committee on Aging, U.S. Senate /$fstatement of John E. Dicken
210  1$a[Washington, D.C.] :$cU.S. Govt. Accountability Office,$d[2010]
215   $a1 online resource (15 pages) $cillustrations
225 1 $aTestimony ;$vGAO-10-529T
300   $aTitle from PDF title screen (GAO, viewed May 7, 2010).
300   $aFor release ... March 17, 2010."
320   $aIncludes bibliographical references.
410  0$aTestimony ;$vGAO-10-529T.
517   $aMedicare Part D 
606   $aMedicare$xEconomic aspects$zUnited States
606   $aPharmaceutical services insurance$xEconomic aspects$zUnited States
615  0$aMedicare$xEconomic aspects
615  0$aPharmaceutical services insurance$xEconomic aspects
700   $aDicken$b John E$01382684
712 02$aUnited States.$bCongress.$bSenate.$bSpecial Committee on Aging.
712 02$aUnited States.$bGovernment Accountability Office.
801  0$bVVK
801  1$bVVK
801  2$bGPO
906   $aBOOK
912   $a9910697140903321
996   $aMedicare Part D$93477697
997   $aUNINA